الصفحة الرئيسية>>Signaling Pathways>> Others>>Betamethasone 17-benzoate

Betamethasone 17-benzoate

رقم الكتالوجGC33890

بيتاميثازون 17-بنزوات هو ممثل الستيرويد ، والذي يمكن استخدامه في علاج القرحة الفموية المتكررة (RAU)

Products are for research use only. Not for human use. We do not sell to patients.

Betamethasone 17-benzoate التركيب الكيميائي

Cas No.: 22298-29-9

الحجم السعر المخزون الكميّة
5mg
276٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers (RAU).

Betamethasone 17-benzoate is the topical steroid[1]. Betamethasone 17-benzoate is a local corticosteroid[2]. A double-blind study of the effectiveness of Betamethasone 17-benzoate in the treatment of recurrent aphothous ulcers (RAU) is concucted. Betamethasone 17-benzoate is found to be effective in reducing symptoms and shortening healing time but not in preventing recurrences[3].

[1]. Barry BW, et al. Optimization of bioavailability of topical steroids: penetration enhancers under occlusion. J Invest Dermatol. 1984 Jan;82(1):49-52. [2]. ZFA (Stuttgart). 1978 Jul 10;54(19):1031-2. [3]. Merchant HW, et al. Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol. 1978 Jun;45(6):870-5.

مراجعات

Review for Betamethasone 17-benzoate

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Betamethasone 17-benzoate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.